Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans

In response to the Ebola virus (EBOV) crisis of 2013–2016, a recombinant vesicular stomatitis virus (VSV)–based EBOV vaccine was clinically tested (NCT02283099). A single-dose regimen of VSV-EBOV revealed a safe and immunogenic profile and demonstrated clinical efficacy. While EBOV-specific immune r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Poetsch, Joseph H, Dahlke, Christine, Zinser, Madeleine E, Kasonta, Rahel, Lunemann, Sebastian, Rechtien, Anne, Ly, My L, Stubbe, Hans C, Krähling, Verena, Biedenkopf, Nadine, Eickmann, Markus, Fehling, Sarah K, Olearo, Flaminia, Strecker, Thomas, Sharma, Piyush, Lang, Karl S, Lohse, Ansgar W, Schmiedel, Stefan, Becker, Stephan, Addo, Marylyn M
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Major Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350948/
https://ncbi.nlm.nih.gov/pubmed/30452666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy565
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares